Skip to content
Clinical Trials – home
BulgariaBack to Bulgaria

Clinical trials in Montana – page 2

43 clinical trials in Montana, Bulgaria. Every trial is listed in the EU Clinical Trials Register and updated daily.

Montana at a glance
43
clinical trials
  • Research sites0
Type of trial
Recruitment status
Quick filters

43 trials in Montana

Open in trial search

A Study of Depemokimab Compared to Placebo in Adults with Chronic Obstructive Pulmonary Disease and Type 2 Inflammation

Registered drug
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Depemokimab
  • Sponsor:Glaxosmithkline Research & Development Limited

IgA nephropathy

Recruiting

Study of felzartamab compared to placebo in adults with IgA nephropathy

Registered drug
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Codeine Phosphate
  • Sponsor:Biogen Idec Research Limited

Study on Efepoetin Alfa and Darbepoetin Alfa for Treating Anemia in Patients with Chronic Kidney Disease on Dialysis

Registered drugNo placebo
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Darbepoetin Alfa
  • Sponsor:Genexine Inc.

Influenza

Recruiting

Study on Baloxavir Marboxil for Children with Influenza

Registered drugNo placebo
Countries:BulgariaBulgaria
  • Participants:0–17 years
  • Substances:Baloxavir Marboxil
  • Sponsor:F. Hoffmann-La Roche AG

Obesity+1

Not yet recruiting

A Phase III Study of Lenbelintide in Adults with Obesity or Overweight and Weight‑Related Comorbidity Without Type 2 Diabetes

Investigational
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:AZD6234
  • Sponsor:AstraZeneca AB

Obesity

Not yet recruiting

KAI-9531 in Adults With Obesity or Overweight and Diabetes

Investigational
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:HRS 9531

Anaemia of chronic disease

Not yet recruiting

Study on Efepoetin Alfa and Darbepoetin Alfa for Treating Anemia in Patients with Chronic Kidney Disease on Dialysis

Registered drugNo placebo
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Darbepoetin Alfa
  • Sponsor:Genexine Inc.

Study of Verekitug to improve symptoms in patients with moderate to severe chronic obstructive pulmonary disease (COPD)

Investigational
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Human IgG1 kappa monoclonal antibody against CRLF2
  • Sponsor:Upstream Bio Inc.

Influenza

Not recruiting

Study on the Effectiveness of an MF59-Adjuvanted Influenza Vaccine Compared to a Non-Adjuvanted Vaccine in Adults Aged 65 and Older

Registered drugNo placebo
Countries:BulgariaBulgaria
  • Participants:65+ years · Healthy volunteers
  • Substances:A/DARWIN/9/2021 (H3N2) - LIKE STRAIN (A/DARWIN/6/2021, IVR-227)
  • Sponsor:Seqirus UK Limited

Asthma

Not recruiting

Study on the Effectiveness and Safety of Fluticasone Propionate and Salbutamol Sulfate for Asthma in Patients Aged 12 and Older

Investigational
Countries:BulgariaBulgaria
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Salbutamol Sulfate
  • Sponsor:Teva Branded Pharmaceutical Products R&D LLC

Study on the Effectiveness and Safety of Tanimilast for Patients with Chronic Obstructive Pulmonary Disease (COPD) and Chronic Bronchitis

Investigational
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Tanimilast
  • Sponsor:Chiesi Farmaceutici S.p.A.

Study on the Effectiveness and Safety of CHF6001 DPI with Roflumilast for Patients with Chronic Obstructive Pulmonary Disease (COPD) and Chronic Bronchitis

Investigational
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Roflumilast
  • Sponsor:Chiesi Farmaceutici S.p.A.

Other cities in Bulgaria

The busiest research cities in the country

All 53 cities in Bulgaria

Clinical research in Montana

What the registry says about research in the country

01 Respiratory Diseases

Innovative clinical trials focusing on respiratory conditions, including studies of new treatments for COPD, severe asthma, and bronchiectasis. Research evaluates both established and novel therapeutic approaches.

  • Severe Eosinophilic Asthma
  • Chronic Obstructive Pulmonary Disease
  • Respiratory Syncytial Virus

Multiple trials testing triple therapy combinations and novel compounds for improved patient outcomes.

02 Cardiovascular Health

Comprehensive research into cardiovascular diseases, with trials examining new treatments for atherosclerosis and stroke prevention. Studies focus on reducing major adverse cardiovascular events.

  • Atherosclerotic Cardiovascular Disease
  • Hypertriglyceridemia
  • Stroke Prevention

Innovative therapies targeting lipid management and vascular health improvement.

03 Infectious Diseases

Advanced research on viral infections and preventive measures, including studies of novel vaccines and antiviral treatments. Particular focus on respiratory viruses and their complications.

  • Influenza
  • COVID-19
  • Viral Lung Infections

Evaluation of both therapeutic and preventive interventions for viral diseases.

04 Renal Medicine

Specialized trials investigating treatments for chronic kidney disease and related conditions. Research includes both medication efficacy and patient care improvements.

  • Non-diabetic Chronic Kidney Disease
  • Renal Anemia
  • Dialysis Complications

Focus on improving outcomes for patients with kidney-related conditions.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.